Byetta
® (
exenatide) is a prescription medication licensed to treat
type 2 diabetes (also known as noninsulin-dependent
diabetes or adult-onset diabetes). Although Byetta is taken by injection, it is not a form of insulin and is not intended to treat
type 1 diabetes. Byetta is approved only for use in combination with certain oral
diabetes drugs. Interestingly, Byetta was first discovered in the saliva of gila monster lizards.
Byetta is made by Amylin Pharmaceuticals, Inc.
Byetta is an incretin mimetic.
This means that Byetta mimics the actions of incretin hormones in the body. As an incretin mimetic, Byetta increases insulin production in response to meals and decreases the amount of glucose (sugar) that the liver produces. Byetta also slows the emptying of food from the stomach, which reduces the amount of food that people eat.
Because incretin hormones are more active in response to higher blood sugar levels (and are less active in response to low blood sugar), the risk of dangerously low blood sugar (hypoglycemia) is low with Byetta. However, combining Byetta with other diabetes medications to lower blood sugar can increase the risk of hypoglycemia
(see Byetta and Blood Sugar).